Clinical Trials List
Protocol NumberVEG102616
Not yet recruiting
2005-11-01 - 2008-05-15
Phase II
Terminated2
-
Trial Applicant
GlaxoSmithKline
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
215 participants
